$65.80 -0.20 (%) Bristol-Myers Squibb Co - NYSE

Apr. 24, 2015 | 04:00 PM

Partner Headlines

  1. U.S. Tech, Dollar & Health Care ETFs To Watch This Week

    Benzinga | Apr. 26, 2015 | 10:52AM EST
  2. Benzinga's Top Upgrades

    Benzinga | Apr. 21, 2015 | 12:35PM EST
  3. Cancer Drugs Impress Again

    IBD | Apr. 20, 2015 | 18:43PM EST
  4. CAR-T Therapy Stocks Hit Hard Following AACR Data

    Benzinga | Apr. 20, 2015 | 13:44PM EST
  5. Bristol, Merck Cancer Drugs Strut Their Stuff

    IBD | Apr. 20, 2015 | 11:29AM EST
  6. Bristol-Myers scores again

    IBD | Apr. 17, 2015 | 19:01PM EST
  7. It's A Big Weekend For Biotech

    Benzinga | Apr. 17, 2015 | 16:31PM EST
  8. Bristol's Opdivo Scores Again Against Lung Cancer

    IBD | Apr. 17, 2015 | 16:14PM EST
  9. Bristol's Opdivo Scores Again Against Lung Cancer

    IBD | Apr. 17, 2015 | 10:44AM EST
  10. Bristol-Myers Up Big After Drug Study Stopped Early

    Benzinga | Apr. 17, 2015 | 10:23AM EST
  11. AstraZeneca's Onglyza Ups Risk Of Death, FDA Says

    IBD | Apr. 14, 2015 | 14:37PM EST
  12. Benzinga's M&A Chatter for Monday April 13, 2015

    Benzinga | Apr. 13, 2015 | 17:48PM EST
  13. Bristol-Myers Squibb Canada Announces Hepatitis C Cure Rate of 97% in Study of Patients Co-infected with HIV Given 12-week Combination Treatment of Daclatasvir and Sofosbuvir in ALLY-2 Trial

    Benzinga | Mar. 3, 2015 | 06:22AM EST
  14. UPDATE: USDA Approves Supplimental Biologics License

    Benzinga | Mar. 2, 2015 | 09:28AM EST
  15. USDA Accepts Supplemental Biologics License Application for Yervoy As Adjuvant Treatment for Patients with Stage 3 Melanoma Who Are at High Risk of Recurrence

    Benzinga | Mar. 2, 2015 | 09:27AM EST
  16. Bristol Myers Reports Data Supporting Clinical Development Of BMS-955176

    Benzinga | Feb. 26, 2015 | 08:35AM EST
  17. Biotech Pharmacyclics Spikes On Buyout Rumors

    IBD | Feb. 25, 2015 | 14:31PM EST
  18. Bristol-Myers Squibb Launches Phase III Trial Of HIV Drug

    Benzinga | Feb. 25, 2015 | 12:57PM EST
  19. Lannett Joins Big-Game Hunt For Drugmaker Acquisitions

    IBD | Feb. 24, 2015 | 15:58PM EST
  20. Bristol-Myers goes for the gut

    IBD | Feb. 23, 2015 | 18:33PM EST
  21. Drugmaker Mylan Takes Part In Pharma Feeding Frenzy

    IBD | Feb. 23, 2015 | 14:59PM EST
  22. Biocept (BIOC) Soars on Liquid Biopsy Appreciation, Rigel Pharmaceuticals (RIGL) Mega-deal with ...

    GuruFocus | Feb. 23, 2015 | 14:58PM EST
  23. Pharma M&A: Bristol-Myers, Valeant Make Deals

    IBD | Feb. 23, 2015 | 12:41PM EST
  24. Morning Market Gainers

    Benzinga | Feb. 23, 2015 | 09:44AM EST
  25. Evercore ISI Technical Analysis: The 'Single Best Idea'

    Benzinga | Feb. 23, 2015 | 07:34AM EST
  26. Jefferies Names AbbVie As Top Pharmaceutical Pick, Offers Alternative Choices

    Benzinga | Feb. 20, 2015 | 13:10PM EST
  27. Strong Dollar Weakens Views

    IBD | Jan. 27, 2015 | 18:48PM EST
  28. Drugmakers Warn On Dollar

    IBD | Jan. 27, 2015 | 18:47PM EST
  29. Strong Dollar Pins U.S. Corporate Earnings Outlook

    IBD | Jan. 27, 2015 | 18:29PM EST
  30. Drug Firms Report Good Q4, But Outlook Cloudy

    IBD | Jan. 27, 2015 | 18:10PM EST
  31. Strong Dollar Means Flabby Outlook For Some Overseas

    IBD | Jan. 27, 2015 | 13:45PM EST
  32. Bristol, Pfizer, Novartis Forecasts Face FX Pressures

    IBD | Jan. 27, 2015 | 11:57AM EST
  33. Tuesday Morning Movers: Microsoft, Procter & Gamble Tumble Following Earnings

    Benzinga | Jan. 27, 2015 | 09:19AM EST
  34. UPDATE: Bristol-Meyers Squibb Posts Upbeat Q4 Results, Issues Downbeat Forecast

    Benzinga | Jan. 27, 2015 | 08:39AM EST
  35. Earnings Scheduled For January 27, 2015

    Benzinga | Jan. 27, 2015 | 04:34AM EST
  36. Pharmaceuticals Sector To See High Voltage Action in 2015

    GuruFocus | Jan. 23, 2015 | 16:13PM EST
  37. 3 High-Flying Health Care Stock IPOs To Watch In 2015

    IBD | Jan. 21, 2015 | 17:09PM EST
  38. BRISTOL-MYERS SQUIBB

    IBD | Jan. 20, 2015 | 18:44PM EST
  39. Bristol-Myers Squibb Names Caforio CEO, Andreotti To Become Chairman

    Benzinga | Jan. 20, 2015 | 17:09PM EST
  40. Feeling Good With This Med Company

    GuruFocus | Jan. 20, 2015 | 15:12PM EST
  41. 10 Biotech Stories You Might've Missed This Week

    Benzinga | Jan. 15, 2015 | 13:18PM EST
  42. Eli Lilly Has 'Turned The Corner,' Upgraded

    IBD | Jan. 15, 2015 | 11:02AM EST
  43. Celgene Outlook Is Upbeat

    IBD | Jan. 12, 2015 | 18:58PM EST
  44. Celgene, Bristol-Myers Cancer Drug News Lifts Stocks

    IBD | Jan. 12, 2015 | 18:48PM EST
  45. Bristol-Myers Hits 14-Year High On Cancer Drug Trial

    IBD | Jan. 12, 2015 | 14:25PM EST
  46. Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 2

    Benzinga | Jan. 12, 2015 | 11:03AM EST
  47. Morning Market Gainers

    Benzinga | Jan. 12, 2015 | 09:42AM EST
  48. Credit Suisse: Keep An Eye On These 6 Healthcare Stocks In 2015

    Benzinga | Jan. 11, 2015 | 12:59PM EST
  49. What Investors Should Expect From Portola Pharmaceutical's Upcoming Data Readouts

    Benzinga | Jan. 9, 2015 | 12:43PM EST
  50. Jim Cramer Advises His Viewers On Wynn Resorts And Second Sight Medical Products

    Benzinga | Jan. 6, 2015 | 07:53AM EST
Trading Center